Immix Biopharma, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $365.1K | $20.0M | $19.1M |
| Jun 2022 | $977.2K | $19.1M | $18.4M |
| Sep 2022 | $646.5K | $17.4M | $16.9M |
| Dec 2022 | $1.7M | $14.9M | $13.4M |
| Mar 2023 | $1.5M | $13.2M | $11.5M |
| Jun 2023 | $2.4M | $15.6M | $12.7M |
| Sep 2023 | $2.8M | $22.5M | $19.6M |
| Dec 2023 | $3.7M | $19.9M | $17.5M |
| Mar 2024 | $6.7M | $34.3M | $29.3M |
| Jun 2024 | $4.9M | $28.8M | $24.0M |
| Sep 2024 | $7.6M | $25.1M | $19.7M |
| Dec 2024 | $9.7M | $22.9M | $17.7M |
| Mar 2025 | $10.3M | $19.9M | $15.9M |
| Jun 2025 | $11.0M | $15.6M | $11.6M |
| Sep 2025 | $11.8M | $20.1M | $15.9M |
| Dec 2025 | $11.0M | $104.8M | $93.9M |
| Mar 2026 | $11.5M | $95.8M | $79.3M |
| Jun 2026 | $10.2M | $239.1M | $225.5M |